help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Published ahead of print on April 21, 2005, doi:10.1165/rcmb.2004-0414OC

Am. J. Respir. Cell Mol. Biol., Volume 33, Number 1, July 2005, 89-96

A more recent version of this article appeared on July 1, 2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2004-0414OCv1
33/1/89    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Joetham, A.
Right arrow Articles by Gelfand, E. W
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Joetham, A.
Right arrow Articles by Gelfand, E. W

Submitted on December 23, 2004
Revised on April 20, 2005

Airway Hyperresponsiveness in the Absence of CD4+ T Cells After Primary but not Secondary Challenge

Anthony Joetham1, Katsuyuki Takeda1, Christian Taube1, Nobuaki Miyahara1, Arihiko Kanehiro1, Azzeddine Dakhama1, and Erwin W Gelfand1*

1 Department of Pediatrics, National Jewish Medical and Research Center, Denver, CO, USA

* To whom correspondence should be addressed. E-mail: gelfande{at}njc.org.

CD4+ T cells have been shown to play a role in the development of airway hyperresponsivness (AHR) and airway eosinophilia in mice using ablation as well as adoptive transfer experiments. However, as other T cell subsets (CD8, NKT) may play a role in these models, we examined the responses of sensitized CD4-deficient mice following either primary or secondary airway allergen challenge. Following sensitization, CD4-deficient mice was not associated with airway eosinophilia, allergen-specific IgE or elevated levels of IL-4 or IL-13. Increases in lung CD8 T cells and IL-5 were observed and shown to be essential for AHR as demonstrated following CD8 T-cell depletion or anti-IL-5 treatment. In contrast to the response of sensitized CD4-deficient mice to primary allergen challenge, they failed to develop AHR following secondary allergen challenge. Although the importance of this CD4+ T-cell-independent pathway in normal mice is unclear at this time, these studies identify the diversity of cellular pathway which may contribute to the development of AHR following primary allergen exposure of sensitized mice.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2005 American Thoracic Society.